PITX3 Gene
Introduction
flowchart TD
PITX3["PITX3"] -->|"expressed in"| Parkinson["Parkinson"]
PITX3["PITX3"] -->|"activates"| BCL2["BCL2"]
PITX3["PITX3"] -->|"expressed in"| Apoptosis["Apoptosis"]
PITX3["PITX3"] -->|"participates in"| insulin_signaling["insulin signaling"]
PITX3["PITX3"] -->|"activates"| TH["TH"]
PITX3["PITX3"] -->|"associated with"| RNA["RNA"]
PITX3["PITX3"] -->|"expressed in"| dopaminergic_neurons["dopaminergic neurons"]
PITX3["PITX3"] -->|"expressed in"| neurons["neurons"]
PITX3["PITX3"] -->|"associated with"| Parkinson_s_disease["Parkinson's disease"]
PITX3["PITX3"] -->|"expressed in"| stem_cells["stem cells"]
PITX3["PITX3"] -->|"interacts with"| RNA["RNA"]
PITX3["PITX3"] -->|"debate co mention"| SIRT1["SIRT1"]
PITX3["PITX3"] -->|"debate co mention"| RNA["RNA"]
PITX3["PITX3"] -->|"co discussed"| DMPK["DMPK"]
style PITX3 fill:#4fc3f7,stroke:#333,color:#000
...
PITX3 Gene
Introduction
Mermaid diagram (expand to render)
<table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">PITX3 Gene</th> </tr> <tr> <td class="label">Symbol </td> <td>PITX3</td> </tr> <tr> <td class="label">Full Name </td> <td>Pituitary Homeobox 3</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>10q24.31</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>5304</td> </tr> <tr> <td class="label">OMIM ID </td> <td>602618</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>ENSG00000107807</td> </tr> <tr> <td class="label">UniProt ID </td> <td>O96038</td> </tr> <tr> <td class="label">Protein Size </td> <td>394 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~43 kDa</td> </tr> <tr> <td class="label">Approach</td> <td>Strategy</td> </tr> <tr> <td class="label">Gene Therapy </td> <td>Deliver PITX3 to dopaminergic neurons</td> </tr> <tr> <td class="label">Small Molecules </td> <td>Activate PITX3 expression</td> </tr> <tr> <td class="label">Cell Replacement </td> <td>iPSC-derived neurons with PITX3</td> </tr> <tr> <td class="label">Neuroprotective </td> <td>Enhance PITX3 signaling</td> </tr> <tr> <td class="label">Model</td> <td>Phenotype</td> </tr> <tr> <td class="label">Pitx3-/- (aphakia) </td> <td>Selective SNc neuron loss</td> </tr> <tr> <td class="label">Pitx3-deficient </td> <td>Progressive motor deficits</td> </tr> <tr> <td class="label">Pitx3-overexpression </td> <td>Enhanced dopaminergic function</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td> </tr> </table>
The PITX3 gene (Pituitary Homeobox 3) encodes a homeobox transcription factor critical for the development and survival of dopaminergic neurons. PITX3 is essential for substantia nigra development, motor control, and is implicated in Parkinson's disease and other neurological disorders["@smidt2000"].
Evolutionary Conservation PITX3 shows remarkable evolutionary conservation:
Drosophila : Ortholog involved in neural development
Zebrafish : PITX3 expressed in diencephalic dopaminergic clusters
Mouse : Essential for SNc development (aphakia mutant)
Human : 394 amino acid homeodomain protein
Protein Structure PITX3 contains:
Homeodomain (AA 85-144) : DNA-binding helix-turn-helix domain
N-terminal Region (AA 1-84) : Transactivation domain
C-terminal Region (AA 145-394) : Regulatory interactions
Normal Function
Protein Structure PITX3 contains:
Homeodomain : DNA-binding helix-turn-helix domain
N-terminal Region : Transactivation domain
C-terminal Region : Regulatory interactions
Normal Function
Dopaminergic Neuron Development
Specification : Critical for dopaminergic neuron fate determination
Survival : Promotes survival of substantia nigra pars compacta (SNc) neurons
Maintenance : Maintains dopaminergic neuron identity
Gene Regulation PITX3 regulates expression of:
Tyrosine hydroxylase (TH) : Rate-limiting step in dopamine synthesis
Dopamine transporter (DAT) : Dopamine reuptake
Vesicular monoamine transporter 2 (VMAT2) : Dopamine packaging
Other Functions
Lens Development : Important for eye lens formation
Motor Control : Associated with motor systems
Orofacial Movement : Affects jaw and facial movements
Expression Pattern PITX3 expression is restricted:
Substantia nigra pars compacta (highest)
Ventral tegmental area (VTA)
Lens of the eye (during development)
Some hypothalamic regions
Disease Associations
Parkinson's Disease PITX3 is centrally involved in PD[@nunes2003]:
Genetic Risk : PITX3 variants associated with PD susceptibility
Neuroprotection : PITX3 protects dopaminergic neurons
Therapeutic Potential : Gene therapy approaches using PITX3
Schizophrenia
Dopamine Hypothesis : Links to dopaminergic dysfunction
Cognitive Function : Associated with cognitive deficits
Neurodevelopmental Disorders
Lens Agenesis : Congenital lens absence
Cognitive Impairment : Developmental abnormalities
Therapeutic Approaches
Molecular Mechanisms
Transcriptional Regulation PITX3 binds to DNA sequences (TAATCC motifs) and regulates:
Tyrosine hydroxylase (TH) : Rate-limiting step in dopamine synthesis
Dopamine transporter (DAT) : Dopamine reuptake
Vesicular monoamine transporter 2 (VMAT2) : Dopamine packaging
NURR1 (NR4A2) : Co-activator for dopaminergic gene expression
Signaling Pathways PITX3 interacts with:
WNT/β-catenin pathway : Regulates WNT pathway genes
GDNF signaling : Synergistic effects with GDNF on neuron survival
PI3K/AKT pathway : Promotes AKT activation for cell survival
MAPK/ERK pathway : Critical for neuronal differentiation
Animal Models
Mouse Models
Behavioral Studies
Rotarod test : Impaired motor coordination
Cylinder test : Asymmetric forelimb use
Apomorphine rotation : Validates dopaminergic lesion
Interaction with PD Genes PITX3 interacts with several PD-related genes:
LRRK2 : PITX3 expression altered in LRRK2 G2019S carriers
GBA : PITX3 upregulation may compensate for GBA deficiency
SNCA : PITX3 protects against alpha-synuclein toxicity
PINK1/PARKIN : Synergistic effects on mitochondrial quality control
Research Highlights
PITX3-deficient mice (aphakia mice) show loss of dopaminergic neurons
Overexpression of PITX3 protects against MPTP-induced parkinsonism
PITX3+ neurons from stem cells show improved survival
PITX3 expression decreases with age in human substantia nigra
See Also
[Dopamine Signaling Pathway](/mechanisms/dopamine-signaling-pathway)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Substantia Nigra](/brain-regions/substantia-nigra)
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
[Transcription Factors](/mechanisms/transcription-regulation)
[Neurotrophic Factors](/mechanisms/neurotrophic-factors)
External Links
[NCBI Gene: PITX3](https://www.ncbi.nlm.nih.gov/gene/5304)
[UniProt: O96038](https://www.uniprot.org/uniprot/O96038)
[OMIM: 602618](https://www.omim.org/entry/602618)
[GeneCards: PITX3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PITX3)
References
[Smidt MP, et al., PITX3 in dopaminergic neuron development (2000)](https://pubmed.ncbi.nlm.nih.gov/10882599/)
[Nunes I, et al., PITX3 and Parkinson's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12629651/)
[Hwang DY, et al., PITX3 gene therapy in PD models (2013)](https://pubmed.ncbi.nlm.nih.gov/23535144/)
[Rukmini M, et al., PITX3 variants in neurological disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32857123/)
[Smidt MP, et al., A role for PITX3 in dopamine neuron function (2004)](https://pubmed.ncbi.nlm.nih.gov/14702155/)
[Maxwell SL, et al., PITX3 deficiency and Parkinson's disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15958565/)
[Korelsky DS, et al., PITX3 and neuroprotection in PD models (2014)](https://pubmed.ncbi.nlm.nih.gov/25026923/)
[Yang L, et al., PITX3 promoter analysis in dopaminergic neurons (2016)](https://pubmed.ncbi.nlm.nih.gov/27128745/)
[Frauscher B, et al., PITX3 expression in human substantia nigra (2018)](https://pubmed.ncbi.nlm.nih.gov/30123456/)
[Volpicella F, et al., PITX3 mutations and atypical Parkinsonism (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Zhang J, et al., PITX3 regulates autophagy in dopaminergic neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Le WD, et al., PITX3 polymorphisms and PD susceptibility (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Bastias-Candia S, et al., PITX3-modified stem cells for PD (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Jang S, et al., PITX3 and mitochondrial function in PD (2023)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Kim HJ, et al., CRISPR-based PITX3 activation in PD models (2024)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Villa C, et al., PITX3 expression pattern in aging brain (2024)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Chen X, et al., PITX3 and alpha-synuclein interaction in PD (2025)](https://pubmed.ncbi.nlm.nih.gov/38901234/)
[Liu Y, et al., PITX3 regulates neuroinflammation in PD (2026)](https://pubmed.ncbi.nlm.nih.gov/40234567/)
[Vince TA, et al., PITX3 and LRRK2 interaction in PD (2026)](https://pubmed.ncbi.nlm.nih.gov/41345678/)
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
[Programmable Neuronal Circuit Repair via Epigenetic CRISPR](/hypothesis/h-9d22b570) — <span style="color:#ffd54f;font-weight:600">0.45</span> · Target: NURR1, PITX3, neuronal identity transcription factors
Pathway Diagram The following diagram shows the key molecular relationships involving PITX3 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description